0000899243-23-000999.txt : 20230105 0000899243-23-000999.hdr.sgml : 20230105 20230105163058 ACCESSION NUMBER: 0000899243-23-000999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAINOVIC SACHA CENTRAL INDEX KEY: 0001053891 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39112 FILM NUMBER: 23511775 MAIL ADDRESS: STREET 1: 126 EAST 56TH STREET STREET 2: 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: InvOpps IV US, L.P. CENTRAL INDEX KEY: 0001745076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39112 FILM NUMBER: 23511776 BUSINESS ADDRESS: STREET 1: 126 EAST 56TH STREET, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-616-2555 MAIL ADDRESS: STREET 1: 126 EAST 56TH STREET, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: InvOpps IV, L.P. CENTRAL INDEX KEY: 0001792575 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39112 FILM NUMBER: 23511777 BUSINESS ADDRESS: STREET 1: 126 EAST 56TH STREET, 20THFLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-616-2555 MAIL ADDRESS: STREET 1: 126 EAST 56TH STREET, 20THFLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: InvOpps GP IV, L.L.C. CENTRAL INDEX KEY: 0001792570 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39112 FILM NUMBER: 23511778 BUSINESS ADDRESS: STREET 1: 126 EAST 56TH STREET, 20THFLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-616-2555 MAIL ADDRESS: STREET 1: 126 EAST 56TH STREET, 20THFLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oyster Point Pharma, Inc. CENTRAL INDEX KEY: 0001720725 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 811030955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 106 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 382-9032 MAIL ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 106 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 1 0001720725 Oyster Point Pharma, Inc. OYST 0001792570 InvOpps GP IV, L.L.C. 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022 1 0 1 0 0001792575 InvOpps IV, L.P. 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022 1 0 1 0 0001745076 InvOpps IV US, L.P. 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022 1 0 1 0 0001053891 LAINOVIC SACHA 126 EAST 56TH STREET, 20TH FLOOR NEW YORK NY 10022 1 0 1 0 Common Stock, par value $0.001 per share 2023-01-03 4 U 0 917768 D 0 I See Footnotes Common Stock, par value $0.001 per share 2023-01-03 4 U 0 1850818 D 0 I See Footnotes Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement") by and among Viatris Inc. ("Viatris") and Viatris's wholly owned subsidiary, Iris Purchaser Inc. dated as of November 7, 2022, these shares of common stock, par value $0.001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive (a) a cash payment of $11.00 per share (the "Cash Amount") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent. Reflects securities directly held by InvOpps IV US, L.P. ("Invus IV US"). Reflects securities directly held by InvOpps IV, L.P. ("Invus IV"). InvOpps GP IV, L.L.C. ("InvOpps GP") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP. Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. INVOPPS IV US, L.P., By: InvOpps GP IV, L.L.C., its general partner, By: /s/ Sacha Lainovic, Name: Sacha Lainovic, Title: Managing Member 2023-01-05 INVOPPS IV, L.P., By: InvOpps GP IV, L.L.C., its general partner, By: Sacha Lainovic, Name: Sacha Lainovic, Title: Managing Member 2023-01-05 INVOPPS GP IV, L.L.C., By: /s/ Sacha Lainovic, Name: Sacha Lainovic, Title: Managing Member 2023-01-05 /s/ Sacha Lainovic 2023-01-05